Commitment to Stem Cell Research & Safety

While the California Stem Cell Treatment Center aims to provide our patients with the most personalized cellular medical care available, we felt it was paramount to demonstrate that the surgery we practice is first and foremost safe. Our very own Mark Berman, MD, of the California Stem Cell Treatment Center is proud to have published one of the largest safety data papers on the use of autologous stromal vascular fraction (SVF) to date, including intravenous infusions. His paper comes from the work of physicians around the globe, their dedication to our institutional review board-approved processes, and their work in tracking patient outcomes through our network-wide database. This effort, which has been underway for over 10 years now, has led us to publish over 12 peer-reviewed publications, the largest of their respective kind, documenting safety and efficacy in orthopedics, urology, neurology, and pain management, which are featured below. Today we are proud to provide our patients with safe and ethical stem cell therapy treatments and we continue to make many advances in our research, aggregating patient data and outcomes network-wide, consistently advancing cellular medicine along the way.


SVF Safety Data Paper

SVF For Chronic Pain

SVF for Knee Osteoarthritis

Ratio of ADSC to HSC to Predict Outcomes

SVF and Intracerebroventricular Injections for Neurodegenerative Disorders

SVF Review

SVF for TBI Laboratory Study

Delivery of oncolytic vaccinia virus

SVF for Interstitial Cystitis

First‑in‑human study of TK‑positive oncolytic vaccinia virus delivered by SVF

SVF and Shock Wave for Erectile Dysfunction

SVF and Shockwave Therapy